Healthcare & Medical Devices Global On demand · 24-48h

Global Medical Grade Gelatin Market Strategic Research Report

Global Medical Grade Gelatin Market Strategic Research Repor…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Medical Grade Gelatin Market
$52.852025
4.3%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Microparticles, Medium-sized, Large-sized

By Application: Uterine Fibroid Embolization (UFE), Liver Tumor Embolization, Arteriovenous Malformation (AVM) Embolization, Hemostasis and Control, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Merit Medical, Boston Scientific, Terumo, Cook Medical, Mermaid Medical, Sirtex Medical, ABK Biomedical, Varian Medical Systems, Medtronic, Teleflex, Jiangsu Hengrui Pharmaceutical Group, Cardiolink Science(shen Zhen)medical Technology Development

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 110 pages
Market size 2025
$52.85
Million USD
Forecast CAGR
4.3%
2025-2032
Forecast 2032
$71
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Medical Grade Gelatin market size is predicted to grow from US$ 52.85 million in 2025 to US$ 75.07 million in 2032; it is expected to grow at a CAGR of 4.3% from 2026 to 2032.

Medical Grade Gelatin is a highly purified, biocompatible protein material derived primarily from collagen found in porcine or bovine sources. It is manufactured under strict pharmaceutical-grade standards to ensure controlled molecular weight, low endotoxin levels, and consistent physicochemical properties. Medical grade gelatin is widely used in pharmaceutical, biomedical, and clinical applications, including absorbable hemostatic agents, embolization materials, hard and soft capsule shells, plasma expanders, tissue engineering scaffolds, and drug delivery systems, due to its excellent biodegradability, safety, and regulatory compliance. In 2025, globalMedical Grade Gelatin production reached approximately 2610 k units, with an average global market price of around US$20.7 usd per unit. The production capacity for Medical Grade Gelatin 2025 was approximately 2700 k units. The typical gross profit margin for Medical Grade Gelatin between 20% and 40%.

The medical grade gelatin market is a specialized segment of the gelatin industry, driven by growing demand from pharmaceutical manufacturing, minimally invasive interventional procedures, and advanced biomedical applications. Key growth drivers include the expansion of capsule-based drug delivery, increasing use of absorbable hemostatic and embolization products, rising surgical volumes, and continuous innovation in regenerative medicine and drug delivery technologies. Compared with food-grade gelatin, medical grade gelatin features higher entry barriers, stricter regulatory oversight, and stronger supplier concentration, with market growth characterized by steady expansion and premium pricing.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Medical Grade Gelatin market?

What factors are driving Medical Grade Gelatin market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Medical Grade Gelatin market opportunities vary by end market size?

How does Medical Grade Gelatin break out by Type, by Application?

This report presents a comprehensive overview of the global Medical Grade Gelatin market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Microparticles
  • Medium-sized
  • Large-sized

Segment by Physical Form

  • Powdered
  • Granular

Segment by Hemostasis Mechanism

  • Physical Embolism Type
  • Coagulation-triggered Type

Segment by Application

  • Uterine Fibroid Embolization (UFE)
  • Liver Tumor Embolization
  • Arteriovenous Malformation (AVM) Embolization
  • Hemostasis and Control
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Medical Grade Gelatin market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Uterine Fibroid Embolization (UFE), Liver Tumor Embolization, Arteriovenous Malformation (AVM) Embolization evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Medical Grade Gelatin Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 4.3%
Regional growth momentum
Market share by segment
Key metrics
Base value
$52.85
2025
Forecast
$71
2032
CAGR
4.3%
2025–2032
Regions
5
global
Key companies
Merit MedicalBoston ScientificTerumoCook MedicalMermaid MedicalSirtex MedicalABK BiomedicalVarian Medical Systems
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
MicroparticlesMedium-sizedLarge-sized
By Application
Uterine Fibroid Embolization (UFE)Liver Tumor EmbolizationArteriovenous Malformation (AVM) EmbolizationHemostasis and ControlOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Microparticles
  • 3.1.3 Medium-sized
  • 3.1.4 Large-sized
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Uterine Fibroid Embolization (UFE)
  • 4.1.3 Liver Tumor Embolization
  • 4.1.4 Arteriovenous Malformation (AVM) Embolization
  • 4.1.5 Hemostasis and Control
  • 4.1.6 Other
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Merit Medical
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Boston Scientific
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Terumo
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Cook Medical
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Mermaid Medical
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Sirtex Medical
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 ABK Biomedical
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Varian Medical Systems
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Medtronic
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Teleflex
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Jiangsu Hengrui Pharmaceutical Group
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Cardiolink Science(shen Zhen)medical Technology Development
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Medical Grade Gelatin market size?
The global Medical Grade Gelatin market is estimated at US$ 52.85 million in 2025 (base year) and is projected to reach US$ 75.07 million by 2032.
What growth rate is expected for the Medical Grade Gelatin market through 2032?
The market is expected to grow at a CAGR of 4.3% from 2026 to 2032, expanding from US$ 52.85 million in 2025 to US$ 75.07 million in 2032, roughly 1.4 times its base-year value.
How is Medical Grade Gelatin defined?
Medical Grade Gelatin is a highly purified, biocompatible protein material derived primarily from collagen found in porcine or bovine sources. It is manufactured under strict pharmaceutical-grade standards to ensure controlled molecular weight, low endotoxin levels, and consistent physicochemical properties.
What are the main segments of the Medical Grade Gelatin market by type?
By type, the market is segmented into Microparticles, Medium-sized and Large-sized.
Which applications drive demand in the Medical Grade Gelatin market?
Key applications covered include Uterine Fibroid Embolization (UFE), Liver Tumor Embolization, Arteriovenous Malformation (AVM) Embolization, Hemostasis and Control and Other.
Who are the key players in the Medical Grade Gelatin market?
Key players profiled include Merit Medical, Boston Scientific, Terumo, Cook Medical, Mermaid Medical, Sirtex Medical, ABK Biomedical and Varian Medical Systems, among 12 companies covered in total.
Which regions and countries are covered for Medical Grade Gelatin?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Medical Grade Gelatin market?
The medical grade gelatin market is a specialized segment of the gelatin industry, driven by growing demand from pharmaceutical manufacturing, minimally invasive interventional procedures, and advanced biomedical applications.
What challenges does the Medical Grade Gelatin market face?
Compared with food-grade gelatin, medical grade gelatin features higher entry barriers, stricter regulatory oversight, and stronger supplier concentration, with market growth characterized by steady expansion and premium pricing.
Who should buy the Medical Grade Gelatin market report?
The report is intended for manufacturers and solution providers, distributors and end users in Uterine Fibroid Embolization (UFE), Liver Tumor Embolization and Arteriovenous Malformation (AVM) Embolization, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Medical Grade Gelatin market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.